TY - JOUR
T1 - Clinical characteristics and outcome correlates of Chinese patients with takotsubo syndrome
T2 - Results from the first Chinese takotsubo syndrome registry
AU - Chong, Tou Kun
AU - Chen, Jian
AU - Lyu, Lingchun
AU - Wei, Yulin
AU - Liu, Yusheng
AU - Wu, Liwen
AU - Tao, Yuan
AU - Jiang, Lingzhi
AU - Sun, Zhongxia
AU - Li, Dabin
AU - Guan, Qianglin
AU - Cheng, Fangyuan
AU - Ding, Yongmin
AU - Miao, Pengfei
AU - Lu, Chenying
AU - Lei, Juan
AU - Wei, Tiemin
AU - Zhu, Tiangang
AU - Liu, Kan
N1 - Publisher Copyright:
© 2023 The Author(s)
PY - 2023/9/15
Y1 - 2023/9/15
N2 - Objective: To investigate clinical features and outcomes of Chinese patients with Takotsubo syndrome (TTS). Methods: We established the first Chinese Registry of Takotsubo Syndrome (ChiTTS Registry) and analyzed demographic, clinical, therapeutical, and outcome data to characterize clinical and outcome features of Chinese TTS patients. Results: In 112 enrolled patients in the ChiTTS registry from 02/01/2016 to 12/28/2021, the mean age was 59.4 ± 18.7 years old, and 27.7% were men. A total of 41.1% patients experienced respiratory and circulatory complications during hospitalization, and 17.3% patients developed cardiogenic shock. Physical triggers, dyspnea, tachycardia, and younger age (< 70 years old) predicted in-hospital complications. The MACCE rate during follow up was 13.9% per patient per year and the rate of all-cause death was 12.8% per patient per year. TTS patients with in-hospital complications developed more long-term MACCE (24.6% vs. 6.6% per patient-year, P < 0.001) and higher all-cause mortality (21.9% vs. 6.6% per patient-year, P = 0.001) than those without. The Kaplan-Meier survival analysis showed that more MACCE occurred in TTS patients with tachycardia during 3-year follow-up (HR 4.18; 95% CI 1.80–9.74; log-rank test P < 0.001). Among all medications at discharge, only beta-blocker was associated with reduced long-term MACCE (HR: 0.35; 95% CI: 0.12–0.996; P = 0.049). Conclusion: We investigated clinical and outcome features of patients in the first Chinese TTS Registry. Tachycardiac TTS patients developed more inpatient and long-term adverse cardiovascular events.
AB - Objective: To investigate clinical features and outcomes of Chinese patients with Takotsubo syndrome (TTS). Methods: We established the first Chinese Registry of Takotsubo Syndrome (ChiTTS Registry) and analyzed demographic, clinical, therapeutical, and outcome data to characterize clinical and outcome features of Chinese TTS patients. Results: In 112 enrolled patients in the ChiTTS registry from 02/01/2016 to 12/28/2021, the mean age was 59.4 ± 18.7 years old, and 27.7% were men. A total of 41.1% patients experienced respiratory and circulatory complications during hospitalization, and 17.3% patients developed cardiogenic shock. Physical triggers, dyspnea, tachycardia, and younger age (< 70 years old) predicted in-hospital complications. The MACCE rate during follow up was 13.9% per patient per year and the rate of all-cause death was 12.8% per patient per year. TTS patients with in-hospital complications developed more long-term MACCE (24.6% vs. 6.6% per patient-year, P < 0.001) and higher all-cause mortality (21.9% vs. 6.6% per patient-year, P = 0.001) than those without. The Kaplan-Meier survival analysis showed that more MACCE occurred in TTS patients with tachycardia during 3-year follow-up (HR 4.18; 95% CI 1.80–9.74; log-rank test P < 0.001). Among all medications at discharge, only beta-blocker was associated with reduced long-term MACCE (HR: 0.35; 95% CI: 0.12–0.996; P = 0.049). Conclusion: We investigated clinical and outcome features of patients in the first Chinese TTS Registry. Tachycardiac TTS patients developed more inpatient and long-term adverse cardiovascular events.
KW - Chinese
KW - Clinical feature
KW - Outcome
KW - Registry
KW - Takotsubo syndrome
UR - http://www.scopus.com/inward/record.url?scp=85164682981&partnerID=8YFLogxK
U2 - 10.1016/j.ijcard.2023.131129
DO - 10.1016/j.ijcard.2023.131129
M3 - Article
C2 - 37355242
AN - SCOPUS:85164682981
SN - 0167-5273
VL - 387
JO - International Journal of Cardiology
JF - International Journal of Cardiology
M1 - 131129
ER -